Drug information for PERMAX
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
EQ 0.05MG BASE
Discontinued
PERGOLIDE MESYLATE
Pergolide
VALEANT PHARM INTL
19385
2009-01-12 Review
2009-01-12 Review
2007-03-29 Other Important Information from FDA
2003-10-10 Label
2003-10-10 Label
2003-10-10 Label
2003-10-09 Letter
2003-10-09 Letter
2003-10-09 Letter
2002-08-29 Letter
TABLET; ORAL
EQ 0.25MG BASE
Discontinued
PERGOLIDE MESYLATE
Pergolide
VALEANT PHARM INTL
"
TABLET; ORAL
EQ 1MG BASE
Discontinued
PERGOLIDE MESYLATE
Pergolide
VALEANT PHARM INTL
"
Drug Adverse Effects information for PERMAX
Role code
Indications
Reaction
# Reports
C
PARKINSON'S DISEASE
ALOPECIA
4
C
PARKINSON'S DISEASE
COMPLETED SUICIDE
2
C
PARKINSON'S DISEASE
DELUSION
4
C
PARKINSON'S DISEASE
HALLUCINATION, AUDITORY
4
C
PARKINSON'S DISEASE
HALLUCINATION, VISUAL
4
C
PARKINSON'S DISEASE
PENILE SIZE REDUCED
4
Ads by Google